62 related articles for article (PubMed ID: 2471207)
1. Structural and immunochemical properties of fetal bovine serum acetylcholinesterase.
Doctor BP; Smyth KK; Gentry MK; Ashani Y; Christner CE; de la Hoz DM; Ogert RA; Smith SW
Prog Clin Biol Res; 1989; 289():305-16. PubMed ID: 2471207
[No Abstract] [Full Text] [Related]
2. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
Johnson G; Moore SW
J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical characterization of anti-acetylcholinesterase inhibitory monoclonal antibodies.
Gentry MK; Saxena A; Ashani Y; Doctor BP
Chem Biol Interact; 1993 Jun; 87(1-3):227-31. PubMed ID: 7688272
[TBL] [Abstract][Full Text] [Related]
4. Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase.
Saxena A; Raveh L; Ashani Y; Doctor BP
Biochemistry; 1997 Jun; 36(24):7481-9. PubMed ID: 9200697
[TBL] [Abstract][Full Text] [Related]
5. Allosteric control of acetylcholinesterase activity by monoclonal antibodies.
Saxena A; Hur R; Doctor BP
Biochemistry; 1998 Jan; 37(1):145-54. PubMed ID: 9425034
[TBL] [Abstract][Full Text] [Related]
6. Natural monomeric form of fetal bovine serum acetylcholinesterase lacks the C-terminal tetramerization domain.
Saxena A; Hur RS; Luo C; Doctor BP
Biochemistry; 2003 Dec; 42(51):15292-9. PubMed ID: 14690439
[TBL] [Abstract][Full Text] [Related]
7. Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease.
Paley EL; Smelyanski L; Malinovskii V; Subbarayan PR; Berdichevsky Y; Posternak N; Gershoni JM; Sokolova O; Denisova G
Mol Immunol; 2007 Jan; 44(4):541-57. PubMed ID: 16616781
[TBL] [Abstract][Full Text] [Related]
8. Characterization of monoclonal antibodies that inhibit the catalytic activity of acetylcholinesterases.
Gentry MK; Moorad DR; Hur RS; Saxena A; Ashani Y; Doctor BP
J Neurochem; 1995 Feb; 64(2):842-9. PubMed ID: 7830078
[TBL] [Abstract][Full Text] [Related]
9. Studies on the topography of the catalytic site of acetylcholinesterase using polyclonal and monoclonal antibodies.
Ogert RA; Gentry MK; Richardson EC; Deal CD; Abramson SN; Alving CR; Taylor P; Doctor BP
J Neurochem; 1990 Sep; 55(3):756-63. PubMed ID: 1696619
[TBL] [Abstract][Full Text] [Related]
10. Anti-epitope antibody, a novel site-directed antibody against human acetylcholinesterase.
Zhang XM; Liu G; Sun MJ
Acta Pharmacol Sin; 2004 Apr; 25(4):431-5. PubMed ID: 15066208
[TBL] [Abstract][Full Text] [Related]
11. Epitopes recognized by anti-reduced and alkylated acetylcholinesterase antibodies.
Wang YX; Xin YB; Sun MJ
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):196-6. PubMed ID: 7526599
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of separate monoclonal antibodies to human acetylcholinesterase and butyrylcholinesterase.
Brimijoin S; Mintz KP; Alley MC
Mol Pharmacol; 1983 Nov; 24(3):513-20. PubMed ID: 6195517
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies.
Fambrough DM; Engel AG; Rosenberry TL
Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1078-82. PubMed ID: 6175961
[TBL] [Abstract][Full Text] [Related]
14. [Study of the structural and functional properties of fibronectin--a high molecular weight plasma glycoproteins--by using monoclonal antibodies].
Chernousov MA; Metsis ML; Glukhova MA; Antonov AS; Orekhov AN
Mol Biol (Mosk); 1984; 18(3):643-52. PubMed ID: 6206390
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody 3F3 against conformational epitope of Torpedo acetylcholinesterase.
Fu FH; Wang YX; Li FZ; Xin YB; Sun MJ
Zhongguo Yao Li Xue Bao; 1997 May; 18(3):284-6. PubMed ID: 10072953
[TBL] [Abstract][Full Text] [Related]
16. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
[TBL] [Abstract][Full Text] [Related]
17. Differences in conformational stability between native and phosphorylated acetylcholinesterase as evidenced by a monoclonal antibody.
Ashani Y; Gentry MK; Doctor BP
Biochemistry; 1990 Mar; 29(10):2456-63. PubMed ID: 1692236
[TBL] [Abstract][Full Text] [Related]
18. Generation of subunit-specific antibody probes for Torpedo acetylcholinesterase: cross-species reactivity and use in cell-free translations.
Lappin RI; Rubin LL; Lieberburg IM
J Neurobiol; 1987 Jan; 18(1):75-99. PubMed ID: 3553428
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a monoclonal antibody, D73H, that maps to a highly conserved region on fibrinogen Bbeta chain.
Rybarczyk BJ; Pereira M; Simpson-Haidaris PJ
Thromb Haemost; 2000 Jul; 84(1):43-8. PubMed ID: 10928468
[TBL] [Abstract][Full Text] [Related]
20. Mapping of SLE-specific Sm B cell epitopes using murine monoclonal antibodies.
Pruijn GJ; Schoute F; Thijssen JP; Smeenk RJ; van Venrooij WJ
J Autoimmun; 1997 Apr; 10(2):127-36. PubMed ID: 9185874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
